Who is the manufacturer of HEPARIN LOCK / FLUSH SYRINGES?

Excelsior Medical Corporation filed the 510(k) submission for HEPARIN LOCK / FLUSH SYRINGES (K133446).

What is the FDA product code for HEPARIN LOCK / FLUSH SYRINGES?

NZW. It is classified under 21 CFR 880.5200 as a Class 2 device in the General Hospital panel.

What is the regulatory pathway for HEPARIN LOCK / FLUSH SYRINGES?

510(k) clearance (submission type: Traditional).

What are the predicate devices for HEPARIN LOCK / FLUSH SYRINGES?

Syrex Pre-Filled Syringe, 10 U/mL & 100 U/mL (K023740); Syrex Heparin Lock Flush Syringe, 1 U/mL & 2 U/mL (K061497).

Who can help prepare an FDA 510(k) submission like HEPARIN LOCK / FLUSH SYRINGES?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

HEPARIN LOCK / FLUSH SYRINGES

K133446 · Excelsior Medical Corporation · NZW · Nov 14, 2014 · General Hospital

Device Facts

Record ID	K133446
Device Name	HEPARIN LOCK / FLUSH SYRINGES
Applicant	Excelsior Medical Corporation
Product Code	NZW · General Hospital
Decision Date	Nov 14, 2014
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 880.5200
Device Class	Class 2
Attributes	Therapeutic

Indications for Use

Flushing of IV catheters and IV tubing only. Solution is intended for maintenance of patency of intravenous injection devices. Prior to and after administration of intermittent medication, entirely flush the intravenous injection device (catheter and or tubing) with Heparin Lock Flush, USP. Use in accordance with any warnings or precautions appropriate to medication being administered. This device is not to be used for anticoagulant therapy.

Device Story

Single-use, pre-filled, terminally sterilized syringes containing heparin sodium USP and 0.9% sodium chloride USP. Used by clinicians to flush IV catheters and tubing to maintain patency between intermittent medication administration, blood sampling, or dialysis. Device connects to standard luer lock/taper valves. Benefits include prevention of catheter occlusion. No clinical decision-making software or automated analysis involved.

Clinical Evidence

Bench testing only. Evidence includes raw material qualification, biocompatibility (ISO 10993-1), stability studies, sterilization validation (ISO 17665-1 and -2), extractables/leachables testing, and final product testing against the Heparin Lock Flush Solution USP Monograph.

Technological Characteristics

Pre-filled syringe; barrel: polypropylene/silicone; plunger: polypropylene; piston: synthetic isoprene rubber; tip cap: polypropylene/TPE. Sterilization: steam (SAL 10^-6). Concentrations: 1, 2, 10, 100 U/mL. Connectivity: none. Software: none.

Indications for Use

Indicated for maintenance of patency of IV catheters and tubing in patients requiring intermittent IV medication, blood sampling, total parenteral nutrition, or hemodialysis. Not for use in anticoagulant therapy.

Regulatory Classification

Identification

An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.

Predicate Devices

Syrex Pre-Filled Syringe, 10 U/mL & 100 U/mL (K023740)
Syrex Heparin Lock Flush Syringe, 1 U/mL & 2 U/mL (K061497)

Submission Summary (Full Text)

{0}------------------------------------------------ Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-000 November 14, 2014 Excelsior Medical Corporation Mr. John Linfante Vice President RA/QA 1933 Heck Avenue Neptune, NJ 07753 Re: K133446 Trade/Device Name: Heparin Lock Flush, USP Regulation Number: 21 CFR 880.5200 Regulation Name: Heparin, Vascular Access Flush Regulatory Class: II Product Code: NZW Dated: October 16, 2014 Received: October 16, 2014 Dear Mr. Linfante We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. Tejashri Purohit-Sheth, M.D. Tejashri Purohit-Sheth, M.D. Clinical Deputy Director DAGRID/ODE/CDRH FOR Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital. Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K133446 Device Name Heparin Lock Flush, USP #### Indications for Use (Describe) Flushing of IV catheters and IV tubing only. Solution is intended for maintenance of patency of intravenous injection devices. Prior to and after administration of intermittent medication, entirely flush the intravenous injection device (catheter and or tubing) with Heparin Lock Solution, USP. Use in accordance with any warnings or precautions appropriate to medication being administered. This device is not to be used for anticoagulant therapy. Heparin Lock Flush, USP is supplied as: - · 3 USP Units per 3 mL (1 USP unit per mL); 3 mL volume in a 10 mL syringe - · 6 USP Units per 3 mL (2 USP unit per mL); 3 mL volume in a 10 mL syringe - · 30 USP Units per 3 mL (10 USP unit per mL); 3 mL volume in a 10 mL syringe - · 50 USP Units per 5 mL (10 USP unit per mL); 5 mL volume in a 10 mL syringe - · 300 USP Units per 3 mL (100 USP unit per mL); 3 mL volume in a 10 mL syringe - · 500 USP Units per 5 mL (100 USP unit per mL); 5 mL volume in a 10 mL syringe | Type of Use (Select one or both, as applicable) | | |----------------------------------------------------------------------------------|----------------------------------------------------------------------| | <input checked="" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) | <input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C) | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ | Manufacturer Name: | Excelsior Medical Corporation | |--------------------|---------------------------------------| | Address: | 1933 Heck Avenue Neptune, NJ 07753 | | Contact Name: | John Linfante | | Title: | Vice President RA/QA | | Phone Number: | 732-643-6088 | | Fax Number: | 732-776-7600 | | Date Prepared: | October 16, 2014 | # 510(k) Summary | Device Proprietary Name: | Heparin Lock Flush, USP | |------------------------------|--------------------------------| | Device Common or Usual Name: | Heparin Lock Flush, USP | | Classification Name: | Heparin, Vascular Access Flush | | Classification Code: | NZW | | Regulation Number: | 21 CFR Part 880.5200 | | Device Classification: | II | ## Predicate Devices: Substantial equivalence is claimed to the following devices as related to intended use, design, and material characteristics: - . Syrex Pre-Filled Syringe, 10 U/mL & 100 U/mL, Excelsior Medical Corporation, K023740 - . Syrex Heparin Lock Flush Syringe, 1 U/mL & 2 U/mL, Excelsior Medical Corporation, K061497 ## Description of the Device Excelsior Medical's Heparin Lock Flush, USP devices are provided as terminally sterilized, single-use, pre-filled, pre-packaged products. The products contain a solution of heparin sodium, USP and 0.9% sodium chloride, USP. The solution is delivered through the luer lock of a venous access device to maintain catheter patency (lock catheters) between treatments. Typically, the venous access device is flushed with normal saline before and after the administration of intermittent medication therapy, blood sampling, total parenteral nutrition, or hemodialysis. Heparin Lock Flush, USP is available as follows: - . Heparin Lock Flush, USP, 3 USP Units per 3 mL (1 USP unit per mL); 3 mL volume in a 10 mL syringe - Heparin Lock Flush, USP, 6 USP Units per 3 mL (2 USP unit per mL); 3 mL volume ● in a 10 mL syringe {4}------------------------------------------------ - Heparin Lock Flush, USP, 30 USP Units per 3 mL (10 USP unit per mL); 3 mL volume in a 10 mL syringe - Heparin Lock Flush, USP, 50 USP Units per 5 mL (10 USP unit per mL); 5 mL volume in a 10 mL syringe - Heparin Lock Flush, USP, 300 USP Units per 3 mL (100 USP unit per mL); 3 mL ● volume in a 10 mL syringe - Heparin Lock Flush, USP, 500 USP Units per 5 mL (100 USP unit per mL); 5 mL volume in a 10 mL syringe The product is intended for use with commercially available valves and catheters fitted with a standard mating luer lock or luer taper. # Intended Use/Indications for Use Flushing of IV catheters and IV tubing only. Solution is intended for maintenance of patency of intravenous injection devices. Prior to and after administration of intermittent medication, entirely flush the intravenous injection device (catheter and or tubing) with Heparin Lock Flush, USP. Use in accordance with any warnings or precautions appropriate to medication being administered. This device is not to be used for anticoagulant therapy. # Technological Characteristics The heparin lock/flush syringes subject to this filing have been previously cleared by FDA under K023740 and K061497. A comparison of the products is provided in the table below. | 510(k) Number | | K061497 | K023740 | |-------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name | Heparin Lock Flush, USP | Syrex Heparin Lock Flush Syringes | Syrex Pre-Filled Syringe | | Manufacturer | Excelsior Medical Corporation | | | | Intended Use | Flushing of IV catheters and IV tubing only. Solution is intended for maintenance of patency of intravenous injection devices. Prior to and after administration of intermittent medication, entirely flush the intravenous injection device (catheter and or | Excelsior Medical Heparin Lock Flush Solutions (1 Unit/mL and 2 Units/mL) are indicated for use in maintaining patency of vascular access devices designed for intermittent or infusion therapy. Prior to and after administration of intermittent medication, entirely | Flushing of IV catheters and IV tubing only. Prior to and after administration of intermittent medication, entirely flush the catheter and/or tubing with Heparin Lock Flush Solution, either USP 10 Units/mL, or USP 100 Units/mL. Use in accordance with | | | tubing) with Heparin Lock Flush, USP. Use in accordance with any warning or precautions appropriate to medication being administered. This device is not to be used for anti- coagulant therapy. | flush the vascular access device with Heparin Lock Flush Solution, USP. Use in accordance with any warning or precautions appropriate to medication being administered. This device is not to be used for anti- coagulant therapy | any warning or precautions appropriate to medication being administered. This device is not to be used for anti- coagulant therapy. Protect from freezing and avoid excessive heat. Store at 25°C (77°F); excursions permitted to 15°- 30°C (59°-86°F). | | Solution | Heparin Lock Flush Solution, USP (0.9% Sodium Chloride Injection, USP) | Heparin Lock Flush Solution, USP (0.9% Sodium Chloride Injection, USP) | Heparin Lock Flush Solution, USP (0.9% Sodium Chloride Injection, USP) | | Concentrations | 1 U/mL 2 U/mL 10 U/mL 100 U/mL | 1 U/mL 2 U/mL N/A N/A | N/A N/A 10 U/mL 100 U/mL | | Single Use Device | Yes | Yes | Yes | | Sterility | Terminally sterilized via steam; SAL 10-6 | Terminally sterilized via steam; SAL 10-6 | Terminally sterilized via steam; SAL 10-6 | | Barrel Material | Polypropylene and silicone lubricant | Polypropylene and silicone lubricant | Polypropylene | | Plunger Rod Material | Medical grade polypropylene | Medical grade polypropylene | Medical grade polypropylene | | Piston | Synthetic isoprene rubber | Synthetic isoprene rubber | Synthetic isoprene rubber | | Tip Cap | Medical grade polypropylene and TPE plus colorant | Medical grade polypropylene and TPE plus colorant | Medical grade polypropylene and TPE plus colorant | | Tip Cap Colorants | 1 U/mL - Green 2 U/mL - Lavender 10 U/mL - Blue 100 U/mL - Yellow | 1 U/mL - Green 2 U/mL - Lavender | 10 U/mL - Blue 100 U/mL - Yellow | | Packaging | Tamper evident over- wrap | Tamper evident over- wrap | Tamper evident over- wrap | {5}------------------------------------------------ As seen above there are no significant differences between the subject and predicate devices. The purpose of this submission is to add alternate suppliers of the heparin sodium (USP) raw material for all of Excelsior Medical's heparin products. {6}------------------------------------------------ # Non-Clinical Testing The following studies have been performed or are being relied upon to support the safety and effectiveness of the product: - Raw material qualification ● - Biocompatibility (ISO 10993-1) ● - Stability Studies ● - Sterilization validation (ISO 17665-1 and -2) ● - Extractables/Leachables - Testing of final product to Heparin Lock Flush Solution USP Monograph ### Conclusion As noted above, the only change to the Heparin Lock Flush, USP products as cleared in K023749 and K061497 is the source of heparin. This change is supported by the studies cited above, and results of the testing show that there are no new questions of safety and effectiveness. Therefore, it is concluded that the product is as safe and as effective for use, and is substantially equivalent to the identified predicate devices.

HEPARIN LOCK / FLUSH SYRINGES

Device Facts

Indications for Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Predicate Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

HEPARIN LOCK / FLUSH SYRINGES

Device Facts

Indications for Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Predicate Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

Create Alert

Search Filters

Agent Token

Connected apps

Welcome

Check your email

Welcome!